• SenesTech, a rodent fertility control innovator, just announced that its ContraPest(R) line of products is now registered for sale and immediate use in Puerto Rico
• Entry into Puerto Rico allows the company to tap into this lucrative market while also offering a viable solution to a problem that has posed a considerable threat to the island
• Fertility control works by fixing the root cause of the problem- rats’ incredible rate of reproduction
• Discussions are underway a large agricultural firm in the region to be the lead customer, opening the company up to new opportunities in the region

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just announced that its ContraPest(R) line of products are now registered for sale and immediate use in Puerto Rico. This adds to the company’s winning streak for the 2023 calendar year, having just recently launched its Evolve(TM) Soft Bait product at Ace Hardware franchise locations in California and closing a public offering that resulted in gross proceeds of $5 million (https://ibn.fm/GhUoI), quintupling its market cap.

Since its inception in 2004, SenesTech has been committed to its mission to improve the health of our world by humanely managing animal populations through fertility control. It has also been guided by the vision to lead responsible and innovative solutions for a better world, embodying five central values – integrity, creativity, urgency, sustainability, and diversity. These have influenced and shaped the four fertility control products for SenesTech, all of which have helped define the brand and mark it as a leader in its space. These include the Ultimate Bait System(TM), Isolate Bait System(TM), and Elevate Bait System(TM) for ContraPest(R) and Evolve(TM) Soft Bait.

With its venture into the Puerto Rico market, SenesTech looks to not only tap into a lucrative market but also offer a viable solution to a problem that has posed a massive threat to society.

“Puerto Rico, as an island nation, is ideally positioned to benefit from ContraPest’s unique fertility control features,” noted Joel Fruendt, SenesTech’s President and CEO.

“Similar to many other islands, rats in Puerto Rico have posed a huge problem for society, whether it be food contamination or destruction, infrastructure damage or public health risks,” he added (https://ibn.fm/Sofe1).

Under threat is Puerto Rico’s grain industry, which has been primarily affected by rat infestations, ultimately posing a threat to the island’s food security. SenesTech looks to address this, mainly by fixing the root cause of the problem -reproduction. Unlike traditional pest control tools like poisons, which are reactive, the company’s approach is more proactive, addressing the main challenge with rats, which is their incredible rate of reproduction.

“Given sufficient food, water, and harborage, which most cities have, two breeding rats can result in 15,000 offspring after a single year. You cannot poison them or trap them, or gas them fast enough to overcome their fertility. You need to control the population by reducing the birth rate, and that is our why,” noted Mr. Fruendt on a Stock2Me Podcast (https://ibn.fm/KzPEi).

SenesTech is currently finalizing plans with a large agricultural firm to be the lead customer in Puerto Rico. They have also completed product registration for Evolve(TM), adding to its line of offerings for this market, and asserting itself as a leader in its space. This foray opens up a new market for the company and new growth opportunities. It reflects the company’s commitment to its mission and vision and its goal to create shareholder value.

“We look forward to bringing our unique rodent control approach to the integrated pest management companies and do-it-yourselfers of Puerto Rico in years to come,” noted Mr. Fruendt.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• Lexaria, a global innovator in drug delivery platforms, expects to submit its IND application for its planned U.S. Phase 1b Hypertension Clinical Trial with the FDA within the next 45 days
• The HYPER-H23-1 clinical study will build on five successful human clinical trials conducted so far, studying the company’s patented DehydraTECH(TM)-processed CBD in an aggregate total of 134 individuals
• Lexaria’s patented DehydraTECH(TM) “drug delivery platform technology” increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced that it anticipates submitting its Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration within the next 45 days. The submission will be for its U.S. Phase 1b Hypertension Clinical Trial, whose primary objective will be to evaluate safety and tolerability in hypertensive patients, with secondary objectives including efficacy evaluation in reducing blood pressure together with detailed pharmacokinetic testing (https://ibn.fm/reNO8). 

The HYPER-H23-1 clinical study, titled “A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of DehydraTECH-CBD in Subjects with Stage 1 or Stage 2 Hypertension” will explore Lexaria’s patented DehydraTECH(TM) technology, specifically its DehydraTECH-processed CBD for the potential treatment of hypertension. It will be a successful build-up from five human clinical trials conducted so far, studying DehydraTECH-CBD in an aggregate total of 134 individuals. Its management is optimistic that these previous studies will contribute to the success of the current one while allowing for the IND review process to run smoothly.

Only a handful of other published research studies have investigated whether a sustained decrease in resting blood pressure is possible following multiple weeks of oral CBD dosing; none of which have been successful in achieving this.. All of the company’s clinical studies showed that DehydraTECH-CBD achieved a sustained decrease in resting blood pressure following multiple weeks of oral dosing. In addition, DehydraTECH-CBD has evidenced superior power to reduce blood pressure, especially compared to other oral CBD formulations. DehydraTECH-CBD has also shown the potential to offer additive blood pressure reduction benefits in addition to any degree of improvement that standard-of-care medications achieved for patients prior to DehydraTECH-CBD dosing, ultimately showing the product’s superiority, overall efficiency, and potential.

Despite having encountered delays before, mainly owing to awaited documentation from one of its key raw material suppliers, Lexaria’s management is excited to submit its IND. Should it be approved, Lexaria will enjoy increased market opportunity for its DehydraTECH technology, specifically its DehydraTECH-CBD. In addition, it will get the company closer to tapping into the cardiovascular drugs market, valued at $138.33 billion in 2022 and expected to hit $200.9 billion by 2032 (https://ibn.fm/c9oox).

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Correlate recently completed solar projects for American Tire Distributors’ headquarters and Continental Envelope’s manufacturing plant
• The projects are a major milestone in Correlate’s initiative to showcase a powerful link between sustainability and profitability
• The global renewable energy market was valued at $881.7 billion in 2020 and is expected to reach $1,977.6 billion by 2030, growing at a CAGR of 8.4%
• To drive shareholder value, Correlate is leveraging a three-pronged strategy enhanced by current investment trends – sell, retain, and acquire

Correlate Energy (OTCQB: CIPI), a growth-oriented distributed energy company, recently announced the successful completion of solar projects for American Tire Distributors’ headquarters and Continental Envelope’s manufacturing plant, and the commencement of a third project in Reading, Pennsylvania. These projects help further the company’s mission to capitalize on America’s unstoppable trend toward decentralized energy generation – emphasizing both the affordability and potential profit the company’s environmental, social, and governance (“ESG”) related energy solutions offer companies and organizations.

The first project was completed at American Tire Distributors (“ATD”) headquarters in Huntersville, North Carolina. The initiative aims to reduce ATD’s carbon footprint and generate substantial cost savings by reducing reliance on traditional energy sources. Over the next two decades, it’s expected to reduce CO2 emissions by 5,463 tons.

“We are thrilled to unveil this remarkable project, reflecting our dedication to providing clients with best-in-class sustainability solutions and reducing their carbon footprint,” said Todd Michaels, Correlate’s CEO (https://ibn.fm/oFtnx). “Completing this project at another nationally recognized headquarters building is a major milestone as this initiative showcases the powerful link between sustainability and profitability.”

The second solar project was constructed at Continental Envelope’s manufacturing plant in Geneva, Illinois, one of Illinois’ largest rooftop solar facilities. Continental Envelope serves prominent clients in various industries and has integrated the clean energy system into its 84-year-old printing facility, producing 2 billion envelopes annually. This solar project will provide approximately 20%-25% of the facility’s energy needs, ensuring energy stability and promoting sustainability for years.

The third project in Reading, Pennsylvania, which has grown from 3.8 MW to 5.2 MW, is the company’s largest project to date. When completed, it will be among Pennsylvania’s largest corporate solar installations (https://ibn.fm/mYoho).

These projects exemplify Correlate’s commitment to delivering customized energy solutions that benefit businesses and the environment. Correlate has identified several key economic drivers powering the decentralized energy trend, including:

• Real Cost Savings – Customers pay zero money down and get an instant electrical discount to current rates.
• Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
• Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for ten years of market support.
• Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

According to Allied Market Research, the global renewable energy market was valued at $881.7 billion in 2020. By 2030, it is expected to reach $1,977.6 billion, growing at a CAGR of 8.4%. Several factors driving renewable energy worldwide include increased output efficiency, less pollution, and low maintenance costs (https://ibn.fm/ALF23).

Clean energy earnings are being sought after by investors. To drive shareholder value, Correlate is leveraging a three-pronged strategy enhanced by current investment trends – sell, retain, and acquire. The Correlate team consists of multi-decade experts who have worked with renowned global brands that are positioning the company to make the most of opportunities while consolidating a fragmented industry. The team has developed, financed, and deployed over $2 billion in clean energy projects to date.

For more information, visit the company’s website at www.Correlate.Energy.

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Sekur expects to launch its Sekur Enterprise suite in mid-January 2024 to offer comprehensive security features designed to meet enterprises’ demands worldwide
• Sekur Enterprise will include SekurMessenger for Enterprise and SekurRelay
• Sekur recently signed distributor agreements in Jordan and Qatar, including Beyond Limits Programs and Electronics (“BLPE”), a Qatari corporation

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0), a leading Swiss-hosted secure and private communications platform, recently announced significant developments that will revolutionize the world of private and secure communications – including the launch of Sekur Enterprise plus a signed distribution agreement with Qatar.

The upcoming launch of the Sekur Enterprise suite of privacy communication solutions is scheduled for mid-January 2024. This suite will offer a comprehensive range of features designed to meet the demands of enterprises worldwide. Several customers across Latin America, the USA, and the Middle East Gulf countries, are eagerly awaiting the release of Sekur Enterprise (https://ibn.fm/icEFi).

The key features of Sekur Enterprise include:

• SekurMessenger for Enterprise: A secure messaging solution for businesses with features to control communications, ensuring compliance, security, and privacy.
• SekurRelay: An innovative solution that enables tight information flow control, catering to enterprise customers’ needs. It will be proposed to telecom operators in various regions, including Latin America, starting in Q1 2024.

Several existing distributors are ready to launch Sekur Enterprise in Latin America and beyond. In Latin America, America Movil’s Telcel is set to launch SekurMessenger for Enterprise, targeting financial institutions and large enterprises seeking a secure alternative following WhatsApp’s recent bans by many financial and government institutions.

The company has introduced SekurRelay Enterprise Email Solution as part of its Sekur Enterprise suite. This solution enables corporate executives and management to seamlessly integrate SekurMail’s privacy and security features without migrating their entire company email domain. This innovative “Inbound Relay” approach allows businesses to protect C-level and management level emails from Business Email Compromise (“BEC”) attacks without disrupting their existing IT infrastructure.

Sekur has also signed distribution agreements in Jordan and Qatar and is discussing with distributors in the United Arab Emirates. These distributors actively engage with leading telecom operators to promote Sekur Enterprise and Sekur Business solutions for small and large enterprises.

Sekur has signed a distribution agreement with Beyond Limits Programs and Electronics (“BLPE”), a Qatari corporation (https://ibn.fm/GHqK5). This agreement covers the State of Qatar and extends to sales support and new distribution setups for Gulf Cooperation Council (G.C.C.) countries. BLPE, instrumental in introducing Sekur to other regions, including Jordan and Iraq, is working closely with Sekur to expand distribution and support across the Middle East, including the United Arab Emirates and Saudi Arabia.

With the Middle East witnessing increased cyber-attacks, Sekur aims to offer its robust and secure communications platform to businesses and governments in the region. Alain Ghiai emphasized, “We can offer the only Swiss-hosted, proprietary, private, and secure communications platform, reducing the risk of cyber penetration for businesses and governments in the region.”

Alain Ghiai, CEO of Sekur Private Data, shared his excitement about these developments. “We are excited to launch our anticipated Sekur Enterprise solutions globally. The first phase has already been launched with our SekurRelay feature, followed by an expanded SekurMessenger,” Ghiai said. “Sekur Enterprise will significantly increase the average revenue per user by up to 280%, offering a truly independent, private, and secure means of communication.”

Sekur recognizes the growing importance of online privacy and security. Therefore, SekurVPN, a privacy VPN solution, has been integrated into its offerings. This VPN solution enhances internet connection encryption, safeguarding users’ identities from malicious hackers. Approximately 50% of Sekur’s customers have chosen to include SekurVPN in their bundles, highlighting the demand for enhanced online privacy and security.

For more information, visit the company’s website at www.SekurPrivateData.com or the company’s product site at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

• Canadian metals supply company Ucore Rare Metals Inc. is focused on establishing North American independence in the production of rare earth elements (“REEs”) vital to modern computerized technologies
• China currently dominates the global market for mining, processing and product creation for REEs, raising concerns that governmental controls over its industries could hamstring supplies Western nations need for everything from cell phones to fighter jet parts
• Ucore is preparing to establish commercial operations for REE refining and processing using the company’s trademarked RapidSX(TM) solution, which has demonstrated significant economical and environmental improvement over the standard SX separation technology
• The company recently announced execution of a tax exemption contract in Louisiana, where it will build the first commercial facility, and the company has selected initial construction contractors to get the process under way

Strategic metals enterprise Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is wrapping up the year by presenting its shareholders a soft construction launch for work at the Louisiana site where the company will build its important rare earth element (“REE”) processing plant.

Ucore announced on December 12 that Louisiana’s governor has executed the contract that will exempt Ucore from some $8.2 million in projected taxes over the next decade, that construction engineering services and construction contracting services subcontractors have been selected, and that members of the Louisiana site program team have begun the “copy & paste” transition process of adapting the technology tested at Ucore’s Canadian demonstration site to the Louisiana facility.

“The recent trip to Ucore’s Kingston, Ontario, RapidSX(TM) Demo Plant really reinforced the size, scale, and importance to North America of what Ucore is working to accomplish for the electric vehicle industry,” Ralph Hennessy, the director of the Louisiana “England Airpark” site, stated in the company’s news release about the progress (https://ibn.fm/dVOzc). “They have assembled a very capable team to construct their facility at the England Airpark, representing a significant milestone in Louisiana’s pathway to a multi-energy economy.”

Ucore’s “Strategic Metals Complex” (“SMC”) in Louisiana represents the fulfillment of efforts to establish a Western-nation supply chain for REEs that is not dependent on China’s industrial domination in the industry. REEs perform crucial functions in modern computerized technologies.

“Knowing that we have local, regional and state support, coupled with federal support through the U.S. Department of Defense and, most recently, from the Government of Canada truly provides a North American solution as we focus on keeping manufacturing jobs in the United States and Canada,” Ucore VP & Chief Operating Officer Mike Schrider, P.E., stated.

For months, Ucore has been demonstrating the capability of RapidSX(TM) REE processing technology in a head-to-head output challenge against the industry standard for REE solvent extraction (known as CSX, or simply SX) at the test facility in Kingston, Ontario. The SMC in Alexandria, Louisiana, will use RapidSX(TM) to produce REEs at commercial scale, building up to 7,500 metric tons of total rare earth oxide (“TREO”) production from an initial 2,000 metric tons startup.

While China has developed its REE mining and processing industries, similar industries in the Americas and other nations have virtually disappeared during recent decades because of economic factors and pollution concerns. RapidSX(TM) offers an improvement over the standard process for teasing the 17 REE metals out of their host ores — a complex process Ucore is managing with a smaller footprint and less demand for electricity.

“The (standard) rare earths refining process can be very finicky,” University of Arizona’s mining and geological engineering department chief Kray Luxbacker told The Economic Times recently (https://ibn.fm/Ltjng). “There are just so many complex steps.”

Once the Louisiana SMC is operational and receiving feedstock from Western mining operations, Ucore will beginning turning its sights toward building two additional planned SMCs in the United States and Canada. The company also owns a rare earths deposit in Alaska that it may tap to mine REEs itself at some point in the future.

For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

• More than a trillion dollars is being invested in clean-energy technologies worldwide
• Vision Marine Technology’s proprietary powertrains will be the inaugural electric motors installed on the Four Winns H2e Bowrider
• Order for E-Motion(TM) 180E outboard and powertrain systems marks beginning of transformative partnership with Wired Pontoons

The worldwide clean-energy movement is happening at an amazing rate, according to a recent NPR interview, with an estimated $1.7 trillion being invested in related technologies (https://ibn.fm/LxNBh). Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, is pioneering the clean-energy transition on the water, selling 100% electric boats, outboard motors and technology to the marine industry.

“Thing are moving at such an astonishing pace,” reported the NPR piece, which noted that “huge swaths” of the country are turning away from fossil fuels as an energy source and investing in other renewable energy sources. “An astonishing stat was this year, about $1.7 trillion worldwide was going to be invested in clean energy technologies — wind, solar power, electric vehicles, nuclear batteries — compared with $1 trillion on fossil fuels. So the amount of money going into it is just staggering. And we keep seeing these records broken.

“The International Energy Agency, for years, they would put out this forecast of how much wind, how much solar, how many electric vehicles they expect in the coming years,” the report continued. “And every year, it would turn out that they just way underestimated the speed of the transition. So it’s something that’s caught even the experts who study this for a living by surprise.”

Vision Marine Technologies is certainly part of this tide of green-energy transformation. In the last several weeks, the company announced the “landmark” delivery of its E-Motion(TM) Electric Powertrain technology to the production facility of Groupe Beneteau, Four Winns (https://ibn.fm/YqUVH). According to the company, these powertrains will be the inaugural electric motors installed on the Four Winns H2e Bowrider.

Calling the delivery “a strategic move to underscore the dawn of a new era in ecofriendly marine transport,” Vision Marine noted that the Four Winns boats will be showcased at the elite Dusseldorf boat show in Europe in January 2024. Recognized for presenting breakthroughs in the boating world, the show offers an ideal platform to highlight the exceptional capabilities and innovations of the E-Motion(TM) powered boats. After the show, stated the company, the E-Motion(TM) 180E equipped boats will be delivered to their ultimate owner, marking a significant milestone: the first-ever electric boats coming off the Four Winns production line destined for consumer ownership.

“The pioneering efforts of Groupe Beneteau and their dedicated production team in crafting a specialized assembly line for electric boats not only sets the course for the future but also fortifies Four Winns with a distinct advantage against any subsequent boat manufacturer venturing into electrification,” said Vision Marine CEO Alexandre Mongeon.

In addition, Vision Marine announced that it had received an initial purchase order from Wired Pontoons for its proprietary E-Motion(TM) 180E outboard and powertrain systems (https://ibn.fm/hyjJK). The order “marks the beginning of a transformative partnership,” VMAR officials noted, as Wired is committed to respond to the growing marine consumer demand for electric marine propulsion.

Wired has spent the last year extensively testing the performance of its pontoons equipped with Vision Marine’s systems, resulting in this inaugural order. “We are excited to collaborate with Vision Marine, starting with an order of 25 E-Motion systems,” said Wired president Curt Jensen. “Over the past 12 months, we’ve seen a decline in the demand for internal combustion engine pontoons, with our customers increasingly seeking ecofriendly alternatives. After evaluating various options, we found the E-Motion(TM) system to be the ideal fit for our clientele.”

Mongeon noted that the U.S. pontoon market is significant, and pontoon users are prime candidates for the E-Motion(TM) 180E. “Since 2021, several pontoon brands have been testing our systems, and we are honored that Curt Jensen’s Wired Pontoons has joined this pioneering group,” he said.

Vision Marine Technologies is in the business of designing and manufacturing electric outboard powertrain systems and related technologies. The company strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power.

For more information, visit the company’s website at www.VisionMarineTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to VMAR are available in the company’s newsroom at https://ibn.fm/VMAR

• U.S. existing home sales have suffered a precipitous decline, driven lower by higher interest rates and a lack of supply
• The Hamptons real estate market has remained largely unscathed, with median home sales prices over 65% higher than those achieved in 2019
• Mountain Top Properties have looked to capitalize on the seaside enclave’s historic popularity through the launch of its dedicated Mountain Top Capital Fund I
• In partnership with Joseph Kelley’s On Site Builder Construction, the fund is looking to raise up to $75 million to construct and sell a range of finished, turnkey properties located across Long Island’s East End

U.S. existing home sales dropped to their lowest level in over 13 years in October, dragged lower by the highest mortgage rates in two decades whilst a dearth of housing supply also barred buyers from entering the market. A large factor behind the drop in property market transactions can be attributed to higher interest rates; the average rate for 30-year fixed-rate mortgages averaged 7.31% towards the end of September, prior to peaking at 7.79% in late October – the highest level since November 2020.

“The combination of high prices, high mortgage rates, and millions of homeowners unwilling to move, given they’ve locked in low rates, has frozen the market,” said Robert Frick, corporate economist at Navy Federal Credit Union in Vienna, Virginia (https://ibn.fm/i0AYg).

Despite moderating trends across much of the United States’ real estate market, the Hamptons has largely emerged unscathed. Historically perceived as a luxury seasonal market, characterized by a significant number of ‘second homes’ and a surfeit of cash buyers, the East End of Long Island has come to be renowned for its property market’s relative immunity to cyclical trends elsewhere in the nation.

Whilst the Covid years of 2020 and 2021 broke all records – in 2020, over $8.1 billion worth of real estate was transacted in the Hamptons, nearly twice the total of the previous year – the area’s property sector has remained relatively stable in its wake.

“[Whilst median home sales prices in the Hamptons have seen] a slight dip  of 7.75% to $1,637,500 for this year — YET — that’s a BIG YET — looking back at our 2019 Mid-Year Report and we see the Median Home Sales Price was $995,000,” remarked Judi Desiderio, CEO of Town & Country Real Estate in reference to the property prices in the popular seaside enclave, which currently trade at an average 65% premium to its pre-Covid averages (https://ibn.fm/aGJcY).

It is this evergreen popularity which Mountain Top Properties (OTC: MTPP), a diversified real estate holding company focused around acquiring, marketing and operating assets through its wholly owned affiliates, have sought to capitalize upon. Group subsidiary, Mountain Top Realty Inc. have sought to gain share within the Hampton’s real-estate market through the provision of finished, turnkey properties – a marked contrast to the Hampton’s historical affinity for one-off, customized home sales.

Through its Mountain Top Capital Fund I, Mountain Top Realty has sought to raise $75 million to acquire, build, renovate and remarket homes in the Hamptons; thus far, the fund has already received debt capital commitments amounting to 70 percent of their anticipated real estate acquisition costs as well as a further 100 percent of the planned construction costs – and will look to deploy $10 million soon to leverage strategic waterfront opportunities within the exclusive enclave.

More critically, Mountain Top Realty has entered partnership with On Site Builder Construction, who will spearhead the design and construction aspects of the ambitious project. Helmed by Hamptons real-estate market stalwart, Joseph Kelley, the real estate firm have designed and built some of the Hamptons’ flagship properties over the past four decades – including the construction of the region’s most expensive properties in 2019 and 2022.

Targeting a minimum ROI of 20 to 30 percent per transaction, Mountain Top Properties eventually anticipates translating its experience and expertise within the Hamptons’ competitive property market to other high-end real estate markets through future dedicated funds.

For more information, visit the company’s website at www.Mountain-Top-Properties.com.

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom at https://ibn.fm/MTPP

• DLMI recently announced that global media leader Marty Pompadur has joined the company as a strategic advisor
• The company is creating a conglomerate with multiple subsidiaries operating in many industries, including television, film, music, entertainment, intellectual property, hospitality, technology, and food and beverage
• DLMI intends to fuel these subsidiaries’ growth, with the aim of eventually spinning them off into their own standalone IPOs once they achieve profitability and self-sufficiency
• The company has brought on board strategic advisors with vast experience in the various industries it is targeting
• DLMI is building a hybrid model that blends traditional securities, such as stock and bonds (and we operate in that public security and stock environment), with SEC-registered security tokens

Diamond Lake Minerals (OTC: DLMI), a multi-strategy company combining its old-school business model, centered around traditional securities like stock and bonds, with new school mechanisms such as security tokens to provide shareholder value, is working to become a conglomerate.

Under the guidance of Michael Reynolds, the company’s President and Director, and Brian J. Esposito, the CEO, DLMI is keen on identifying in multiple industries promising opportunities that it can bring into its fold through acquisitions or buildout from scratch, creating multiple subsidiaries. The company intends to then allocate capital and provide access to advisors, know-how, and other resources to support and fuel the growth of these companies.

“The whole idea is wealth enhancement, wealth preservation for our shareholders, getting these entities to be performant to their maximum capacity, and, with the assistance of our advisors and our great experienced management team that we keep adding to our arsenal, getting these companies to be very profitable and self-sufficient to [then] spin them off into their own standalone IPOs at some point,” shared Esposito during an interview with Proactive’s Steve Darling (https://ibn.fm/WJQak).

DLMI has its sights set on a number of industries, including, but not limited to, television, film, music, entertainment, intellectual property, hospitality, technology, and food and beverage (“FNB”), and is bringing on board advisors with years of experience in these industries. “If you look at the advisors, and more are coming, you will see the industries that we will be heavily participating in; a lot of those are industries they have held exceptional careers in,” explained Esposito in a November Bell2Bell Podcast episode (https://ibn.fm/7WN0J).

For instance, Diamond Lake Minerals recently announced that global media leader Marty Pompadur has joined the company as a strategic advisor. Pompadur, who is looking forward to leveraging his experience to contribute to the company’s continued success, has had an illustrious career in the media and entertainment industry, where he has held both junior and senior roles since transitioning from his law practice in 1960 (https://ibn.fm/pVR4T).

Pompadur’s first role in the media field was at the American Broadcasting Companies, Inc. (“ABC, Inc.”), where he worked until 1977. During this 17-year stint, Pompadur was appointed to the ABC, Inc. Board of Directors, becoming the youngest member ever. After leaving ABC, Pompadur took up the role of president of Ziff Corp. until his departure in 1982. Ziff Corp. was the holding company for both Ziff-Davis Broadcasting Company, which ran six network-affiliated TV stations, and Ziff-Davis Publishing Company, one of the largest publishers of consumer special interest magazines and business publications (https://ibn.fm/0OLGR).

Between 1982 and 2008, Pompadur held leadership roles at RP Companies’ various private and public limited partnerships, which operated TV stations, radio stations, and cable television stations, and News Corporation. He is recognized for advising News Corporation in acquiring the Metromedia TV station group and coming up with the business plan for the Fox Television Network in 1985. Pompadur is now involved in many companies as a board member, advisor, and investor.

“We are honored to welcome Marty Pompadur to Diamond Lake Minerals as a strategic advisor. His remarkable career and unparalleled expertise will be instrumental in guiding our strategic initiatives. Marty’s wealth of experience will undoubtedly play a pivotal role in our mission to achieve sustained growth and value creation,” said Esposito of Pompadur’s addition to the advisory team.

Pompadur joins an experienced group of advisors, including Brandon Fugal, Chairman of Colliers International in Utah and Co-Founder of multiple ventures; Anthony Scaramucci, the Founder and Managing Partner of SkyBridge; Larry Namer, the Founder of E! Entertainment TV and President of Metan Global; Andrew Fromm, the Founder of Fromm Consulting; Raul Leal, the CEO of SH Hotels & Resorts; Michael Malik Sr., a prominent entrepreneur and leader in casino development; and Agnes Budzyn, the Managing Partner of Bluedge Ventures.

Looking ahead and leveraging the guidance of its strategic advisors, DLMI hopes to build a hybrid model that blends traditional securities, such as stock and bonds (and we operate in that public security and stock environment), with SEC-registered security tokens. To that end, the company plans to introduce security token offerings through its private partnership with INX.

Under this arrangement, each of DLMI’s subsidiaries will have a security token offering in the market, enabling the company to raise capital and involve investors who are otherwise wary of digital assets like cryptocurrencies and NFTs, a feat Pompadur lauded, noting, “The company’s innovative approach to digital assets aligns with the dynamic evolution in the industry.”

In addition, for information on the company’s security token SEC-regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• A number of U.S. cities are reporting an increase in complaints about more brazen rat populations, prompting officials in New York City and elsewhere to devote greater revenues to control measures
• While many rodent control efforts involve traps and poisons, Arizona-based SenesTech Inc., is successfully marketing a one-of-a-kind non-lethal alternative that focuses on chemically preventing rats from birthing an astronomical number of pups throughout the year
• The company recently rolled out a soft bait fertility control product, adding it to its existing liquid product, opening up the vast professional and consumer rodent control market
• SenesTech also recently closed a public offering that will add $5 million to its balance sheet for further development of fertility control for animal pest populations

Rodent control innovator SenesTech (NASDAQ: SNES) is adding approximately $5 million to its balance sheet that it can use for research and development, capital expenditures, working capital, and general and administrative expenses, as well as potential acquisitions.

SenesTech recently closed a public offering of 3.8 million shares of its common stock and accompanying warrants to help advance its corporate strategies (https://ibn.fm/fXvTU). The company has been in a growth phase that includes the introduction of a soft bait fertility control product.

SenesTech’s Evolve(TM) Soft Bait joins its trademarked liquid ContraPest(R) bait as non-lethal methods of controlling rat populations by limiting the fertility of male and female pests that may carry diseases, damage infrastructure and destroy stored foods.

“We are addressing one of the world’s most challenging problems — rodent control — through a completely different way than has ever been done before, by addressing the root cause of the problem — reproduction,” SenesTech President and CEO Joel Fruendt said during an October interview for the Lytham Partners Fall 2023 Investor Conference (https://ibn.fm/kCcv6). “The existing solutions’ effectiveness, namely poisons that are in the marketplace, are limited by rats’ reproduction rates, resistance and aversion, as well as the enhanced social and political limitations on the use of poison.”

After New York City created its office of “rat czar” (or, director of rodent mitigation) earlier this year to deal with its “public enemy number one” (https://ibn.fm/9hpwo), other cities dealing with infestations have taken note.

Boston’s public 311 service request database has catalogued more than 3,900 rodent-related complaints so far this year about the increasingly brazen behavior of rats, prompting calls to centralize rodent control efforts under one office much like New York’s effort (https://ibn.fm/OMgGV). In Chicago, more than 50,000 such complaints were filed with the city last year (https://ibn.fm/hc8pO). 

SenesTech is offering its products to pest management professionals and directly to consumers through the company’s e-commerce portal and through big box retailers. The contraceptive bait is designed to be easy to use, and attractive to rats so that they continue to consume it, bringing greater results over time (https://ibn.fm/RmLeL).

“We have been consistently growing revenues with an 87 percent CAGR over the past few years,” Fruendt said.

Q3 revenue announced Nov. 9 was $360,000, an increase of 44 percent over $250,000 in Q3 2022. The company’s gross profit margin during the same period was 49 percent, growing from $122,000 in 2022 to $176,000 in 2023 (https://ibn.fm/ORMCH).

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• Clene, a late clinical-stage biopharmaceutical company, creates clean-surfaced, catalytically active nanocrystals that directly modulate biological systems, including the central nervous system, by improving mitochondrial health
• The company’s lead investigational candidate, CNM-Au8(R), is currently in development as a disease-modifying treatment for people living with specific types of neurodegenerative disorders (“ND”), namely amyotrophic lateral sclerosis (“ALS”), Parkinson’s Disease, and multiple sclerosis (“MS”)
• Neurodegenerative disorders are characterized by neurodegeneration – the progressive loss of neuron structure, neuronal functions, and finally, the neurons themselves
• Nanotherapeutics are in development to stop or reverse neurodegeneration using novel approaches to address the mitochondrial deficits and bioenergetic crises common to these neurodegenerative diseases

Also known simply as nerve cells, neurons are central to most – if not all – of the body’s normal functions, from breathing and talking to eating, thinking, and walking (https://ibn.fm/zWMUR). They support these activities by sending and receiving information between the brain and muscles, and are also responsible for receiving sensory input from the external environment and relaying that information to the brain.

As crucial as neurons are, they are not immortal. Like all other cells in the body, nerve cells undergo apoptosis, which is the programmed process by which body cells die. Apoptosis helps remove surplus, aged, damaged, or unwanted cells. However, in some cases, apoptosis becomes dysregulated, leading to the premature loss of central nervous system cells (https://ibn.fm/DqqvW) as is seen in neurodegeneration.

“Diseases with neurodegeneration as their hallmark feature are collectively termed as neurodegenerative disorders (‘NDs’). The most common NDs include Alzheimer’s disease, Parkinson’s disease, prion disease, amyotrophic lateral sclerosis (‘ALS’), motor neuron disease, Huntington’s disease, spinal muscular atrophy, and spinocerebellar ataxia,” explains a 2022 study (https://ibn.fm/qldhY).

While NDs affect millions worldwide and continue to be a growing concern, their treatment have only utilized small molecule or biologic approaches. More progress is needed as a number of challenges remain, ranging from lack of efficacy to lack of delivery of sufficient amounts of active drug to the brain across the blood brain barrier.

Fortunately, in recent years, nanotechnology has revolutionized the healthcare sector, facilitating the development of nano-sized therapeutic drugs or nanotherapeutics. These nanotherapeutics, whose sizes range between 1 and 100 nm, are positioned as a possible alternative for stopping or reversing neurodegeneration thanks to their unique mechanisms of action and their potential ability to efficiently cross the blood-brain barrier without altering or damaging it.

The therapeutic potential of nanoparticles has piqued the interest of Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinical-stage biopharmaceutical company focused on the discovery and development of innovative, life-changing medicines for people with serious and life-threatening diseases. The company has created and refined a proprietary electro-crystallization-method that results in clean-surfaced, catalytically active nanocrystals that directly modulate biological systems, including the central nervous system, by improving mitochondrial health.

“Multiple lines of evidence now point to energetic failure as a key contributor to neurodegenerative disease. Neurons and their associated support cells, in particular oligodendrocytes, are amongst the highest energy-consuming cells in the body: the brain represents only 2% of the human body weight, yet it consumes over 20% of the body’s metabolic energy. As humans age, our cell’s ability to convert food into energy in the form of ATP becomes less efficient. Eventually, the nervous system’s demand for ATP surpasses the cell’s ability to supply it, and as a consequence, neurons begin to fail and subsequently die,” explains the company in its 2022 annual report (https://ibn.fm/QsZVY).

Clene’s preclinical studies have shown that its lead investigational candidate CNM-Au8, an oral suspension of clean-surfaced, catalytically-active gold nanocrystals, crosses the blood-brain barrier and gives the neurons and associated support cells an energetic boost or helps improve energy production and utilization to enhance survival. The preclinical studies eventually transitioned into clinical studies, which have demonstrated promising results.

Recently, the company reported a 75% decreased risk of death, and a statistically significant 52% decreased risk of ALS clinical worsening events (defined as first occurrence of any of the following: death, tracheostomy, assisted ventilation, or feeding tube placement) in ALS clinical trial participants treated with CNM-Au8 following long-term analysis. A separate long-term follow-up analysis also showed that treatment with CNM-Au8 significantly improved survival in ALS patients (https://ibn.fm/Ne9PJ). Because individuals diagnosed with ALS typically live an average of 3-5 years beyond their diagnosis, a drug that has potential to affect lifespan garners great interest, especially if the drug is shown to be safe with minimal side effects. To date, Clene has reported over 500 years of human subject exposure without any serious adverse events attributed to the drug across all its clinical programs.

CNM-Au8 is currently in development as a disease-modifying treatment for people living with ALS, Parkinson’s Disease, and MS. ALS is an ND that affects motor neurons, the neurons in the brain and spinal cord that control breathing and voluntary muscle movements, causing these nerve cells to degenerate and die. Parkinson’s Disease is caused by the death of nerve cells that produce dopamine. These cells are located in the basal ganglia, an area of the brain that controls movement. As a result, Parkinson’s Disease patients experience unintended or uncontrollable movements and difficulty with coordination and balance. MS is a disorder in which the immune system cells attack and eat away at the substance that covers the nerves known as myelin. In MS, multiple neuronal subtypes can be affected by demyelination, and subsequently die as a result of myelin loss. In all of these diseases, studies have shown that mitochondrial dysfunction precedes neuronal death. By targeting mitochondrial function with the innovation of catalytically-active gold nanocrystals, Clene aims to develop a first-in-class drug to address these diseases with few treatment alternatives and significantly high unmet needs.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN